The global chronic disease management market is set to grow significantly, with an estimated increase of USD 4610.51 million from 2023 to 2027, driven by technological advancements such as AI. This growth is expected to continue at a CAGR of 11.09% over the forecast period. Technavio’s latest market research report highlights the key role of digital technologies and AI in enhancing patient outcomes for chronic diseases like cardiovascular diseases, cancer, diabetes, and musculoskeletal disorders. Companies like Biofourmis are introducing AI-driven virtual care services to improve quality of life for patients and enable early intervention. Telehealth services are revolutionizing care delivery, allowing healthcare professionals to monitor, diagnose, and treat patients remotely, ensuring better coordination of treatment and therapies.
The increasing prevalence of chronic diseases necessitates the use of innovative solutions to manage conditions effectively. Technologies like mobile apps, patient devices, and software systems play a crucial role in delivering high-quality medical services and monitoring patients in real-time. Regulations around data privacy ensure the confidentiality of personal medical information, especially concerning biomarkers for disease management. Consulting services further enhance the overall care experience by providing expert advice and guidance.
The market overview of the Chronic Disease Management market highlights the use of advanced technologies like artificial intelligence and machine learning to improve patient outcomes and reduce healthcare costs. The market is expected to grow significantly due to the rising burden of chronic diseases and the adoption of innovative solutions by healthcare providers and payers.
Key companies in the Chronic Disease Management market compete to gain greater market share and leverage technological advances to position themselves effectively. The market is fragmented, with companies focusing on product launches, sustainability, and market prospects to stay competitive. Leading vendors in the market include ALLSCRIPTS HEALTHCARE SOLUTIONS INC., Cognizant Technology Solutions Corp., Epic Systems Corp., and Koninklijke Philips NV.
Technavio is a trusted global technology research and advisory company providing actionable insights to help businesses identify market opportunities and optimize their market positions. With a team of over 500 specialized analysts, Technavio offers comprehensive coverage of emerging market trends and technologies, assisting enterprises of all sizes in making informed decisions.
For more information on the Chronic Disease Management market and the latest industry trends, download a FREE sample report from Technavio’s website today.
Photo – https://mma.prnewswire.com/media/2386804/20240415081325_bw_2023_v1.jpg?p=original
Source link
